Barr P J, Tomei L D
LXR Biotechnology Inc., Richmond, CA 94804.
Biotechnology (N Y). 1994 May;12(5):487-93. doi: 10.1038/nbt0594-487.
In a landmark paper published over two decades ago, Kerr et al. proposed the term apoptosis "for a hitherto little recognized mechanism of controlled cell deletion, which appears to play a complementary but opposite role to mitosis in the regulation of animal cell populations". In the ensuing years, this natural cell death process was studied at the basic science level, primarily with a view to understanding its roles in cancer and in the development and maintenance of the immune system. More recently, however, evidence has suggested a role for the failure of normal apoptosis control in many of the major diseases of the industrialized world. Though complex, apoptosis appears amenable to therapeutic intervention. The range of modern pharmaceutical strategies available to treat such disregulated gene-directed processes offers promise for advances in the control of cancer, immune system and neurodegenerative disorders, heart disease, and perhaps even the aging process itself.
二十多年前发表的一篇具有里程碑意义的论文中,克尔等人提出了“细胞凋亡”这个术语,用于描述一种迄今为止鲜为人知的受控细胞清除机制,该机制在动物细胞群体的调节中似乎与有丝分裂起到互补但相反的作用。在随后的几年里,这一自然细胞死亡过程在基础科学层面得到了研究,主要目的是了解其在癌症以及免疫系统发育和维持中的作用。然而,最近有证据表明,正常细胞凋亡控制的失败在工业化世界的许多主要疾病中都起到了一定作用。尽管细胞凋亡很复杂,但似乎可以通过治疗手段进行干预。现有的一系列用于治疗此类失调的基因导向过程的现代药物策略,为癌症、免疫系统和神经退行性疾病、心脏病,甚至可能是衰老过程本身的控制取得进展带来了希望。